Abstract
The aim of this study was to analyse relationship between changes of the stroma and expression of tenascin-C (TN-C) and laminin in prostate carcinoma. Tenascin-C immunostaining was increased, and laminin decreased in carcinomas compared with peritumoural tissue and benign prostate hyperplasia (P<0.05). Statistical analysis confirmed connection between stromal changes and TN-C expression in prostate carcinoma (P<0.05). Gleason pattern 3 carcinomas showed more pronounced stromal reaction and TN-C expression compared with Gleason pattern 4 carcinomas (P<0.05). The main cells in prostate cancer stroma are myofibroblasts that are also responsible for tenascin production. Degradation of laminin was not connected with myofibroblastic stromal changes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hayward SW, Cunha GR, Dahiya R . Normal development and carcinogenesis of the prostate. A unifying hypothesis. Ann NY Acad Sc 1996; 784: 50–62.
Tomas D, Kruslin B . The potential value of (myo)fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinoma. Prostate 2004; 61: 324–331.
Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR . Reactive stroma in human prostate cancer: introduction of myofibroblast phenotype and extracellular matrix remodeling. Clin Caner Res 2002; 8: 2912–2923.
Sappino AP, Schurch W, Gabbiani G . Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990; 63: 144–161.
Kammerer R, Ehret R, von Kleist S . Isolated extracellular matrixbased three-dimensional in vitro models to study orthotopically cancer cell infiltration and invasion. Eur J Cancer 1998; 34: 1950–1957.
Merker HJ . Morphology of the basement membrane. Microsc Res Tech 1994; 28: 95–124.
Patarroyo M, Tryggvason K, Virtanen I . Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Bio 2002; 12: 197–207.
Colognato H, Yurchenco PD . Form and function: the laminin family of heterotrimers. Dev Dyn 2000; 218: 213–234.
Pupa SM, Menard S, Forti S, Tagliabue E . New insight into the role of extracellular matrix during tumor onset and progression. J Cell Physiol 2002; 192: 259–267.
Sounni NE, Noel A . Membrane type-matrix metalloproteinase and tumor progression. Biochimie 2005; 87: 329–342.
Chiquet-Ehrismann R . Tenascin and other adhesion-modulating proteins in cancer. Semin Cancer Biol 1993; 4: 301–310.
Erickson HP . Tenascin-C, tenascin-R, and tenascin-X: a family of talented proteins in search of their functions. Curr Opin Cell Biol 1993; 5: 869–876.
Orend G . Potential oncogenic action of tenascin-C in tumorigenesis. Int J Biochem Cell Biol 2005; 37: 1066–1083.
Vollmer G . Biologic and oncologic implications of tenascin-C/hexabrachion proteins. Crit Rev Oncol/Hematol 1997; 25: 187–210.
De Marzo AM, Nelson WG, Isaacs WB, Epstein JI . Pathological and molecular aspects of prostate cancer. Lancet 2003; 361: 955–964.
Martin M, Pujuguet P, Martin F . Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. Pathol Res Pract 1996; 192: 712–717.
Noel A, Foidart JM . The role of stroma in breast carcinoma growth in vivo. J Mammary Gland Biol Neoplasia 1998; 3: 215–225.
Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335–348.
Rowley DR . What might a stromal response mean to prostate cancer progression? Cancer Metast Rev 1998; 17: 411–419.
Tuxhorn JA, Ayala GE, Rowley DR . Reactive stroma in prostate cancer progression. J Urol 2001; 166: 2472–2483.
Gabbiani G . The myofibroblasts in wound healing and fibrocontractive diseases. J Pathol 2003; 200: 500–503.
Wever DO, Mareel M . Role of tissue stroma in cancer cell invasion. J Pathol 2003; 200: 429–447.
Orimo A, Tomioka Y, Shimizu Y, Sato M, Oigawa S, Kamata K et al. Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression. Clin Cancer Res 2001; 7: 3097–3105.
Orlandini M, Oliveiro S . In fibroblasts VEGF-D expression is induced by cell-cell contact mediated by cadherin-11. J Biol Chem 2001; 276: 6576–6581.
Xue Y, Li J, Latijnhouwers MA, Smedts F, Umbas R, Aalders TW et al. Expression of periglandular tenascin-C and basment membrane laminin in normal prostate, benign prostatic hyperplasia and prostate carcinoma. Br J Urol 1998; 81: 844–851.
Ibrahim SN, Lightner VA, Ventimiglia JB, Ibrahim GK, Walther PJ, Bigner DD et al. Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma. Hum Pathol 1993; 24: 982–989.
Slater MD, Lauer C, Gidley-Baird A, Barden JA . Markers for the development of early prostate cancer. J Pathol 2003; 199: 368–377.
Xue Y, Smedts F, Latijnhouwers MA, Ruijter ET, Aalders TW, de la Rosette JJ et al. Tenascin-C expression in prostatic intraepithelial neoplasia (PIN): a marker of prognosis? Anticancer Res 1998; 18: 2679–2684.
Bair EL, Chen ML, McDaniel K, Sekiguchi K, Cress AE, Nagle RB et al. Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration. Neoplasia 2005; 7: 380–389.
Udayakumar TS, Chen ML, Bair EL, Von Bredow DC, Cress AE, Nagle RB et al. Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration. Cancer Res 2003; 63: 2292–2299.
Koyama S . Coordinate cell-surface expression of matrix metalloproteinases and their inhibitors on cancer-associated myofibroblasts from malignant ascites in patients with gastric carcinoma. J Cancer Res Clin Onco 2005; 23: 1–6.
Ottino P, He J, Axelrad TW, Bazan HE . PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. Invest Ophthalmol Vis Sci 2005; 46: 487–496.
Yasui H, Andoh A, Bamba S, Inatomi O, Ishida H, Fujiyama Y . Role of fibroblast growth factor-2 in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human intestinal myofibroblasts. Digestion 2004; 69: 34–44.
Hindermann W, Berndt A, Haas KM, Wunderlich H, Katenkamp D, Kosmehl H . Immunohistochemical demonstration of the gamma2 chain of laminin-5 in urinary bladder urothelial carcinoma. Impact for diagnosis and prognosis. Cancer Detect Prev 2003; 27: 109–115.
Linder S, Castanos-Velez E, von Rosen A, Biberfeld P . Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. Hepatogastroenterology 2001; 48: 1321–1327.
Murai S, Umemiya T, Seiki M, Harigaya K . Expression and localization of membrane-type-1 matrix metalloproteinase, CD 44, and laminin-5gamma2 chain during colorectal carcinoma tumor progression. Virchows Arch 2004; 445: 271–278.
Brar PK, Dalkin BL, Weyer C, Sallam K, Virtanen I, Nagle RB . Laminin alpha-1, alpha-3, and alpha-5 chain expression in human prepubertal [correction of prepubetal] benign prostate glands and adult benign and malignant prostate glands. Prostate 2003; 55: 65–70.
Davis TL, Cress AE, Dalkin BL, Nagle BL . Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma. Prostate 2001; 46: 240–248.
Hao J, Jackson L, Calaluce C, McDaniel K, Dalkin BL, Nagle RB . Investigation into the mechanism of the loss of laminin 5 (α3β3γ2) expression in prostate cancer. Am J Pathol 2001; 158: 1129–1135.
Hao J, Yang Y, McDaniel K, Dalkin BL, Cress AE, Nagle RB . Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate. Am J Pathol 1996; 149: 1341–1349.
Acknowledgements
This work was supported by grants 0108001/02 (BK) and 0134002/02 (MB) from Ministry of Science and Technology, Republic of Croatia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tomas, D., Ulamec, M., Hudolin, T. et al. Myofibroblastic stromal reaction and expression of tenascin-C and laminin in prostate adenocarcinoma. Prostate Cancer Prostatic Dis 9, 414–419 (2006). https://doi.org/10.1038/sj.pcan.4500874
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.pcan.4500874
Keywords
This article is cited by
-
High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting
Pathology & Oncology Research (2018)
-
Expression analysis of α-smooth muscle actin and tenascin-C in the periodontal ligament under orthodontic loading or in vitro culture
International Journal of Oral Science (2015)
-
Periacinar Retraction Clefting in Nonneoplastic and Neoplastic Prostatic Glands: Artifact or Molecular Involvement
Pathology & Oncology Research (2012)
-
Periacinar Retraction Clefting and D2-40 Expression in Prostatic Adenocarcinoma
Pathology & Oncology Research (2012)
-
Peritumoral Retraction Clefting Correlates with Advanced Stage Squamous Cell Carcinoma of the Esophagus
Pathology & Oncology Research (2008)